MPLT — MapLight Therapeutics, Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1770069 ·
Last close
$6.57
Market Cap
$286.78M
52W High
$40.43
52W Low
$6.06
ADV30
368,442
Next earnings
2026-11-16

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 — -55,343,000 -51,616,000 477,183,000 55,568,000 31,412,000
Jun 2026 0 — -63,548,000 -60,192,000 368,348,000 71,633,000 20,049,000
Mar 2026 0 — -64,503,000 -60,668,000 418,788,000 55,707,000 18,954,000
Dec 2025 0 — -83,377,000 -79,548,000 479,512,000 46,729,000 21,140,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-174,668,000
Investing CF
$-250,430,000
Financing CF
$463,264,000
CapEx
$-453,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-5.84
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-481,380,000
Inventory
—
Receivables
—
ST Investments
$233,092,000
EBIT TTM
$-242,926,000
Pretax Income TTM
$-229,826,000
Interest Exp TTM
—
Analysts
13

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -169,083,000 -161,152,000 479,512,000 21,140,000 458,372,000 -138,137,000
Dec 2024 — — — — 21,721,000 115,195,000 —
Dec 2023 — — — — 20,127,000 71,282,000 —
Dec 2022 — — — — 18,519,000 20,870,000 —

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
$368,348,000
Forward EPS
$-3.30

Max Pain — expiry 2027-02-19

max pain strike: $10.00 · spot: $6.65 · call oi: 549 · put oi: 466
Expected Move to 2027-02-19: ±$7.50 (112.78%) — implied range $-0.85 – $14.15 · ATM straddle on $7.50 strike

Peers — same industry

TickerNameMarket CapLastDaily %
FULC Fulcrum Therapeutics, Inc. $286.43M $3.75 —
EBS Emergent BioSolutions Inc. $288.44M $5.61 —
VCRE Vicore Pharma Holding AB $285.02M $10.12 —
BNTC Benitec Biopharma Inc. $284.35M $8.15 —
EVMN Evommune, Inc. $290.28M $7.02 —

News headlines (Yahoo Finance, 1h cache)

MapLight Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
2026-11-16 12:15 · Yahoo
MapLight Therapeutics to Participate in Upcoming Investor Conference
2026-11-09 21:05 · Yahoo
Down 29.2% in 4 Weeks, Here's Why You Should You Buy the Dip in MapLight Therapeutics, Inc. (MPLT)
2026-10-16 12:35 · Yahoo
Down 34.8% in 4 Weeks, Here's Why MapLight Therapeutics, Inc. (MPLT) Looks Ripe for a Turnaround
2026-10-14 12:35 · Yahoo
MapLight Therapeutics Celebrates Co-Founder Dr. Karl Deisseroth on Receipt of 2026 Nobel Prize in Physiology or Medicine for the Development of Optogenetics
2026-10-06 11:00 · Yahoo
MapLight Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
2026-08-13 20:05 · Yahoo
MapLight Therapeutics Launching $150 Million Private Placement Financing
2026-08-13 13:47 · Yahoo
MapLight Therapeutics Announces $150 Million Private Placement Financing
2026-08-13 13:10 · Yahoo
MapLight Therapeutics stock crashes on Phase II schizophrenia data
2026-07-28 15:06 · Yahoo
MPLT Stock Plunges 73% — Wipes Out Over $1B In Market Cap After Trial Miss On Once-Daily Dose
2026-07-27 23:08 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.